Control of locomotion in marine mollusc Clione limacina. X. Effects of acetylcholine antagonists.
The swimming central pattern generator (CPG) of the pteropod mollusc Clione limacina is located in the pedal ganglia. It consists of three groups of interneurons (7, 8, and 12) which generate the rhythmical activity and determine the temporal pattern of the motor output, that is, phasic relations between different groups of motor neurons supplying dorsal (group 1 and 3 motor neurons) and ventral (group 2 and 4 motor neurons) muscles of the wings. In this work peripheral and central effects of acetylcholine (ACh) antagonists on the swimming control in C. limacina has been studied. The ACh antagonist atropine blocked transmission from the wing nerves to wing muscles, while gallamine triethiodide (Flaxedil), d-tubocurarine, and alpha-bungarotoxin did not affect the neuromuscular transmission. In the pedal ganglia, the ACh antagonists atropine and gallamine triethiodide blocked inhibitory postsynaptic potentials (IPSPs) produced by group 8 interneurons onto group 7 interneurons and motor neurons of groups 1 and 3. d-Tubocurarine and alpha-bungarotoxin did not affect IPSPs produced by group 8 interneurons. Although atropine and gallamine triethiodide blocked IPSPs produced by group 8 interneurons in antagonistic neurons, these drugs did not influence excitatory postsynaptic potentials (EPSPs) produced by group 8 interneurons onto group 12 interneurons. The main pattern of the swimming rhythm with an alternation of two phases of the swimming cycle persisted after elimination of inhibitory connections from group 8 interneurons to antagonistic neurons by the ACh antagonists. This suggests that there are redundant mechanisms in the system controlling C. limacina's swimming. This redundancy ensures reliable operation of the system and contributes to its flexibility.
Panchin
Y V
YV
Institute of Problems of Information Transmission, Academy of Science of Russia, Russia.
Sadreev
R I
RI
Arshavsky
Y I
YI
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004594:Electrophysiology; D007395:Interneurons / Q000187:drug effects / Q000502:physiology; D008124:Locomotion / Q000187:drug effects / Q000502:physiology*; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008839:Microelectrodes; D008974:Mollusca / Q000502:physiology*; D009046:Motor Neurons / Q000187:drug effects / Q000502:physiology; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects / Q000294:innervation / Q000502:physiology; D018377:Neurotransmitter Agents / Q000378:metabolism; D010276:Parasympatholytics / Q000494:pharmacology; D013550:Swimming; D009435:Synaptic Transmission / Q000187:drug effects
D018377:Neurotransmitter Agents; D010276:Parasympatholytics; D001285:Atropine; D000109:Acetylcholine